Related Experiment Videos

Zomepirac, interstitial nephritis, and renal failure

P J Mease, A J Ellsworth, P D Killen

Annals of Internal Medicine

|September 1, 1982

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up.

The British journal of dermatology·2021

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.

Arthritis research & therapy·2019

Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019

Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Clinical rheumatology·2018

Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Clinical rheumatology·2018

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group.

Clinical rheumatology·2016

See all related articles